07/10/2025
3:22 PM | ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2025
4:00 PM | 5AM Ventures VI, L.P. (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form SCHEDULE 13D/A | |
07/02/2025
3:40 PM | ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
4:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
8:18 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
4:45 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Beckman Daniella (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lubner David Charles (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/23/2025
4:45 PM | Resnick Joshua (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:47 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:05 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:30 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
11:15 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form EFFECT | |
03/28/2025
3:33 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form PRE 14A | |
03/20/2025
3:45 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2025
3:48 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:01 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
3:29 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:35 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:36 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:19 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:20 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:22 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:23 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
11:15 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form EFFECT | |
01/29/2025
4:24 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 424B3 | |
01/21/2025
3:24 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
5:39 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:41 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:53 PM | Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form SCHEDULE 13D | |
01/02/2025
6:37 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:42 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Banks aren’t ready for this altcoin—are you? (Ad) Our expert analysts have identified a $100 billion gap in the crypto market.
Only one project is perfectly positioned to fill it… Discover our #1 crypto for the market right now. |
12/30/2024
5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
5:52 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma (Filer)
Vor Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:04 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
Vor Biopharma Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free VOR Stock Alerts